This research demonstrates a new electrochemical biosensor for detecting multidrug resistance genes, suggesting innovative applications in cancer diagnosis.
Multidrug resistance genes (MDRG) overexpression represents a critical factor contributing to chemotherapeutic resistance in cancer, necessitating the development of highly sensitive detection technologies for early diagnosis. Herein, we synthesized a heterometallic decanuclear CeIII-WVI cluster incorporated antimonotungstate pentamer Na₁₆H₇[Ce₄W₆O₁₃(H₂O)₁₂][B-α-SbW₉O₃₃]₅·40H₂O (1) via the reaction of the [B-α-SbW₉O₃₃]⁹⁻ precursor with Ce³⁺ cations in CH₃COOH-CH₃COONa buffer system. Its polyanionic architecture comprises a heterometallic decanuclear [Ce₄W₆O₁₃(H₂O)₆]²²⁺ core encapsulated by five [B-α-SbW₉O₃₃]⁹⁻ units. Notably, 1 represents the first reported pentamer within the rare-earth incorporated antimonotungstate family. By employing 1 as a multifunctional dopant, an electroconductive 1@PNMPy film was fabricated through electropolymerization of N-methylpyrrole (NMPy), demonstrating enhanced conductivity and stability. The resulting 1@PNMPy-based electrochemical DNA biosensor (1-ECDB) achieves sensitive detection of MDRG, exhibiting a broad linear response range (1.0 × 10⁻¹⁴ to 1.0 × 10⁻⁷ M) and a low detection limit (4.33 fM). Moreover, the 1-ECDB exhibits acceptable specificity, anti-interference capability, reproducibility and long-term stability. Its practical applicability has been validated in diluted human serum samples, yielding recovery rates ranging from 94.2 to 109.2%. This work pioneers the application of POM-conductive polymer composite films in the electrochemical detection of MDRG, bridging the molecular engineering of POMs with biomedical sensing technologies.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: